Filer Snapshot

DRIEHAUS CAPITAL MANAGEMENT LLC

CIK 0000938206. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.

Entity type

Company

Total filings

76

Latest filing

15 May 2026

Industry

n/a

Filing-backed research brief

Start with the SEC data that changes for this CIK

Latest signal: 13F-HR for Q1 2026. Each card links back to the PortfolioSavvy page where the filing evidence is closest.

Largest parsed holding

TSM

$427.47M reported value

Open holding

13D/G large stake

CRNX

31 Mar 2026 · 6.1% ownership

Open 13D/G

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Source: SEC Form 13F

13F-HR filed on 15 May 2026 for CIK 0000938206.

View source filing
Ownership signals CIK-linked ownership evidence from parsed SEC filings. 1 signal
Parsed SEC ownership signals

Parsed SEC ownership coverage

These bars compare filing-backed value available in each disclosure family. Read them as separate lenses, not as one combined ownership total.

13F portfolio$13.6B

Quarterly institutional holdings reported on Form 13F; not total AUM.

Latest reported 13F value

13F
$13.6B

Reported market value from the latest parsed Form 13F information table; this is not total assets under management.

Source: SEC Form 13FScope: U.S.-listed equity holdings

Largest 13F holdings

13F
TSM PRAX XENE CRNX PL
+15 moreFN APGE LITE CW BAP FTAI EWTX GH SYRE IDCC NXT CRS COHR BE UEC

Largest symbols in the latest parsed Form 13F information table.

Freshness: Latest parsed 13F period

Largest 13F holdings

Largest symbols in the latest parsed Form 13F information table.

TSM PRAX XENE CRNX PL FN APGE LITE
+12 moreCW BAP FTAI EWTX GH SYRE IDCC NXT CRS COHR BE UEC

Largest active 13G stakes

Passive or institutional large-stake positions disclosed in parsed Schedule 13G filings.

XENE CRNX PL APGE PAY QNST
+9 moreSEI KRRO SEPN ANDG DYNX BLFY PTN SRZN Definium Therapeutics, Inc.
How to read these SEC ownership signals
  • Read each filing family separately: Form 13F, Schedules 13D/G, and Forms 3/4/5 answer different SEC disclosure questions and should not be blended into one ownership total.
  • Use 13F values for visible U.S.-listed equity portfolios, 13D/G rows for large beneficial-owner stakes, and Forms 3/4/5 rows for reporting-owner positions and transactions.
  • Open the linked research path when you need the filing, CIK, issuer, CUSIP, date, or source trail behind a value.
At a glance Names, identifiers, and filing context for this profile. 1 identity field
Business address
25 East Erie St, Chicago, IL, 60611
EDGAR profile Static EDGAR fields kept behind disclosure so the main profile stays readable. 3 profile fields available
Incorporated in
DE
Fiscal year end
31 December
Former names on EDGAR
DRIEHAUS CAPITAL MANAGEMENT INC (to 14 Nov 2005)

Filer intelligence

What SEC filings say about DRIEHAUS CAPITAL MANAGEMENT LLC

A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.

Quick read

  • Latest parsed 13F shows $13.6B across 355 reported holdings for Q1 2026.
  • Largest parsed 13F holding: TSM at $427.47M.
  • 5 recent 13D/G stake rows found; top row is CRNX at 6.1% ownership.

SEC source mix

Counts show available parsed rows, not one combined ownership total.

XML parsed
13F portfolio 355 rows

Quarterly institutional portfolio holdings.

Open
13D/G stakes 5 rows

Beneficial ownership and large-stake disclosures.

Open
Forms 3/4/5 No rows yet

Officer, director, and 10% owner holdings or transactions.

Open

Top parsed 13F holdings

Visual share of the latest parsed 13F portfolio. Values are reported market value, not a recommendation.

Q1 2026 - 15 May 2026

Top 5 concentration

11%

Share of latest parsed 13F value represented by the visible holdings below.

Top 5 reported value

$1.45B

Compared with $13.6B total 13F value.

Top 5 net change

-$317.51M

Position-value change inside the visible top holdings only.

13F concentration map

A simple visual split of the latest parsed 13F portfolio.

Largest add: YUMC · Largest trim: TSM

TSM PRAX XENE CRNX PL Other holdings

TSM

3.1%

Tsmc

$427.47M

PRAX

2.2%

Praxis Precision Medicines Inc

$305.83M

XENE

1.9%

Xenon Pharmaceuticals Inc

$261.19M

CRNX

1.7%

Crinetics Pharmaceuticals Inc

$232.3M

PL

1.6%

Planet Labs PBC

$221.33M

13D/G large-stake context

CRNX

31 Mar 2026 · Common Stock

6.1%

ANDG

31 Mar 2026 · Class A Common Stock

4.4%

PTN

31 Dec 2025 · Common Stock

9.8%

Definium Therapeutics, Inc.

31 Dec 2025 · Common Stock

6.6%

Latest update

What changed recently for DRIEHAUS CAPITAL MANAGEMENT LLC

New filing available

Latest Schedule 13D/G period: 31 Mar 2026. Open the source-backed page to inspect the fresh filing or facts context.

Update date

15 May 2026

Page type

Filer profile

Latest period

31 Mar 2026

Schedule 13D/G context is visible from filings filed on 15 May 2026.

Benchmark Context

Benchmark context for this company

DRIEHAUS CAPITAL MANAGEMENT LLC has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.

Compared with

Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.

Why this is notable

Latest Schedule 13D/G period: 31 Mar 2026. That gives you a fresh baseline before you compare this company with peers.

  • Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
  • Open the facts page first if you want the cleanest path to verification.

Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.

SEC filing record

CIK 0000938206 filing coverage

Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.

SEC filings
76
First seen
13 Feb 2014
Latest filing
15 May 2026
Entity
Company

Latest Filings

Showing the latest 12 of 76 SEC filings for DRIEHAUS CAPITAL MANAGEMENT LLC.

13F-HR

13F-HR filing

Filing date
15 May 2026
Reporting date
31 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A

SCHEDULE 13G/A filing

Filing date
15 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A

SCHEDULE 13G/A filing

Filing date
15 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A

SCHEDULE 13G/A filing

Filing date
15 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR

13F-HR filing

Filing date
17 Feb 2026
Reporting date
31 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G

SCHEDULE 13G filing

Filing date
17 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G

SCHEDULE 13G filing

Filing date
17 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G

SCHEDULE 13G filing

Filing date
17 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A

SCHEDULE 13G/A filing

Filing date
17 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A

SCHEDULE 13G/A filing

Filing date
17 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A

SCHEDULE 13G/A filing

Filing date
17 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR

13F-HR filing

Filing date
14 Nov 2025
Reporting date
30 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .